Cincinnati Children s Hospital Medical Center PHO/OVPCA Constipation Initiative Monthly Report February 2018

Similar documents
STRENGTHENING THE COORDINATION, DELIVERY AND MONITORING OF HIV AND AIDS SERVICES IN MALAWI THROUGH FAITH-BASED INSTITUTIONS.

Engaging Physicians in Large-Scale Improvement: Lessons Learned from Cincinnati Children s PHO

An Updated Approach to Colon Cancer Screening and Prevention

FGSZ Zrt. from 28 February 2019 till 29 February 2020 AUCTION CALENDAR: YEARLY YEARLY BUNDLED AT CROSS BORDER POINTS

CONTROL CHART METHODOLOGY

Sleep Market Panel. Results for June 2015

Flu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

McLean ebasis plus TM

Flu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Texas Vendor Drug Program Specialty Drug List Process. February 2019

APPENDIX ONE. 1 st Appointment (Non-admitted) recovery trajectories

The Infection Control Doctor and Clostridium difficile infection. Dr David R Jenkins University Hospitals of Leicester NHS Trust, England

Crisis Connections Crisis Line Phone Worker Training (Online/Onsite) Winter 2019

FAQs about Provider Profiles on Breast Cancer Screenings (Mammography) Q: Who receives a profile on breast cancer screenings (mammograms)?

Organ Donation Breakthrough Collaborative Institute of Medicine

Complete Central Registry Treatment Information Requires Ongoing Reporting and Consolidation Well Beyond 6-Month Reporting

Faster Cancer Treatment: Using a health target as the platform for delivering sustainable system changes

Disclosures. Learning Objectives. Improving HPV Immunization Rates in a Large Pediatric Practice: Implementing Effective Quality Improvement

Curators of the University of Missouri - Combined January 01, 2013 through December 31, 2013 Cost Management Report

IHN-CCO DST Final Report and Evaluation

BJA Performance Measures

Hospital Norovirus Outbreak Reporting

Overview of the Radiation Exposure Doses of the Workers at Fukushima Daiichi Nuclear Power Station

One Palliative Care Annual Report

Published by the Pharmaceutical Services Division to provide information for British Columbia s health care providers

Hand, Foot, and Mouth Disease Situation Update. Hand, Foot, and Mouth Disease surveillance summary

Implementation of an Interprofessional Team to Prevent Inpatient Hypoglycemic Events. September 13, 2016

Opioid Deaths in South Carolina. Daniela Nitcheva, PhD Division of Biostatistics Bureau of Public Health Statistics

Quit Rates of New York State Smokers

Primary Care Behavioral Health Integration:

From Analytics to Action

Assessing Change with IIS. Steve Robison Oregon Immunization Program

Reducing Readmissions and Improving Outcomes at OhioHealth Mansfield Hospital:

Seasonality of influenza activity in Hong Kong and its association with meteorological variations

Consultant-led Referral to Treatment (RTT) waiting times collection timetable: outcome of consultation

GREENWOOD PUBLIC SCHOOL DISTRICT PHYSICAL EDUCATION

End Stage Renal Disease (ESRD) Network Learning and Action Network (LAN) Series: Bloodstream Infection (BSI) Quality Improvement Activity

Blood Pressure Management: A Journey in Quality Improvement Phil E. Yphantides, M.D.

Colorectal Cancer- QI process and clinic success: A Case Study at Atascosa Health Center

Date : September Permit/License or Registration Application. Permit/License/ Notification/ Registration Description. Remark

18 Week 92% Open Pathway Recovery Plan and Backlog Clearance

Region of Waterloo Public Health and Emergency Services Infectious Diseases, Dental, and Sexual Health

Curators of the University of Missouri - Combined January 1, 2016 through December 31, 2016

The CQUIN Learning Network Annual Meeting

Lauren DiBiase, MS, CIC Associate Director Public Health Epidemiologist Hospital Epidemiology UNC Hospitals

Session #206, March 8, 2018 Susan J. Kressly, MD, FAAP, Kressly Pediatrics Dr. Jacques Orces, D.O., Nicklaus Children s Hospital

Vibrio surveillance in the CIDT Era

East London Community Kidney Service

Has the UK had a double epidemic?

MICHIGAN PATHOLOGY QUALITY SYSTEM (MPQS)

What might help reduce waiting times in CAMHS?

Monitoring Protocol for Clozapine-induced Myocarditis. Copyright 2017, CAMH

Dementia Content Report January Produced By The NHS Choices Reporting Team

Avian influenza in poultry, wild and captive birds (AI)

Clostridium difficile (C. difficile) and Staphylococcus aureus bacteraemia (MRSA and MSSA) Bi-annual Report. Surveillance: Report:

Insulin Administration Errors in Adult Community Nursing. Hedy Lehman Assistant Director of Professional Standards, Adult Community Nursing

NCC Pediatrics Continuity Clinic Curriculum: Medical Home Module 2 Well Visits

Global Screening of Hearing in Newborns. Update from Portugal

Utilizing CQI to Improve the Health of Supportive Housing Residents The North American Housing and HIV/AIDS Research Summit VII September 25-27, 2013

th Medical Group Report Card

Collaborative Approach in Managing the High Risk Diabetic Patient in a Patient Centered Medical Home

Marijuana Possession Arrests Continue Under Mayor de Blasio

Health Provider Partnerships for OSA Management in Transportation. Paul S. Valentine Chief Executive Officer Sleep HealthCenters LLC

Core 3: Epidemiology and Risk Analysis

Tri-County Opioid Safety Coalition Data Brief December 2017 Clackamas, Multnomah, and Washington Counties

Status of Implementing Legislation Regarding the Eastern Band of Cherokee Indians

Cancer Immunotherapy Pilot Program/ Patents 4 Patients. USPTO BCP Customer Partnership Meeting Alexandria, VA August 2, 2017

CURRICULUM PACING CHART ACES Subject: Science-Second Grade

CASE STUDY Improving the quality of VMMC services at Mangochi, Mzimba North, and Nkhotakota District Hospitals in Malawi

Empowering Weight Loss Charts & Logs Healthy Weight Chart Cholesterol Chart Blood Pressure Chart Exercise Calorie Burning Chart

RTT Exception Report

Magellan s Transport Route Lead Monitoring Program

Improving care of HIV-infected breastfeeding

GSK Medicine: Study No.: Title: Rationale: Study Period Objectives: Indication: Study Investigators/Centers: Research Methods: Data Source:

EQAS. Hemoglobin Program (BC80) Cycle 12: December 2014 December 2015 Sample No: 1 Sample Date: 17 Dec 14. Exceptions. Customer Information

Implementing Rapid Response Teams (RRT) National Call September 13, 2007

What Computer Tools to Use for Your Quality and Safety Program

South West Cancer Alliances Rapid Diagnostic Pathway for Lung Cancer Project Evaluation

HIV Care & Treatment STATE OF OREGON

Figure 1: Quantity Dispensed/100 Members (Ambien and Sonata on left axis)

Integrated VL/EID& TB Data Review Meeting 23/3/2018 PIATO

March 2012: Next Review September 2012

Surgical Site Infection (SSI) Surveillance Update (with special reference to Colorectal Surgeries)

FAO's initiative on HPAI control in Bangladesh

Cork Integrated Falls Service: New ways of working in specialist, community and continuing care

Development and use of the Eating, Sleeping, Consoling (ESC) Care. for opioid-exposed newborns and their families in Northern New England

Experience with Pyrazinamide and Rifampin Regimens for Latent TB Infection

MHSC Program Evaluation Mental Health Service Corps. Dana Collins, Social Work Intern Jessica Neufeld, MPH Virna Little, PsyD, LCSW-r, MBA, CCM, SAP

TABLE OF CONTENTS INTRODUCTION 1 -SUMMARY OF CONTENTS 2 -DEATHS REPORTABLE TO THE CORONER 3 INVESTIGATIONS, CORONER CASES AND AUTOPSIES 6

The CIDRZ Experience: use of data to understand patient outcomes and guide program implementation 07 January 2010

Successful Falls Prevention in Aged Persons Mental Health. Reducing the risk and decreasing severity of outcome

Dr. Martin has documented that she has nothing to disclose. This pilot project was funded by the Medical University Hospital Authority.

HIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE

Alignment Strategies at the JPS Health Network

Going with the Flow Update. An update and comparative analysis of five years of Water Sentinels flow data collection of the Upper Verde River

IEAG Findings 5-6 December 2005

HRS 2010: Module 2 Health Literacy V000 BRANCHPOINT: IF THIS IS NOT A SELF-RESPONDENT (A009/A155 NOT 1), GO TO END OF MODULES

Symptom Control During Chemotherapy (SCDC) MN Community Measurement

Parity: Innovation in Practice

Transcription:

Cincinnati Children s Hospital Medical Center PHO/OVPCA Constipation Initiative Monthly Report February 2018 Aim: Project focus to embed evidence based protocol for the treatment of Constipation in the community primary care office. Key ou tcomes include reducing constipation related ED visits at CCHMC and unnecessary referrals to the GI division. Population: Children seen by the 175 physicians of the PHO/OVPCA primary care network representing a total population of 240,000 lives in the CCHMC primary service area who are seen by the Pediatrician and receive a first time diagnosis of Constipation. Project Leader: Carl Donisi Analyst: Ursula Bradshaw Senior Application Developer: Huiping Li Key Measures 1. Constipation Symptom Distribution: Among visits associated with a diagnosis of constipation, the proportion of children having: < 2 stools per week, hard or painful stools, stool withholding behavior or soiling Baseline (time period noted) 91.5% 2. Percent Impaction: Among visits to the PCP office associated with a diagnosis of constipation, the proportion of children having impaction 19.6% 3. Percent prescribed a 3-day oral cleanout regimen: Among visits where impaction was documented, the proportion prescribed a 3-day oral cleanout regimen 81.4% 4. Percent with a phone follow up: Among visits where impaction was documented, the proportion associated with a phone follow up encounter within 7-10 days of the visit 55.8% Long- Term Goal (6/17) Desired Direction of Change Short- Term Goal Current Month (Feb-18) N/A 93.4% N/A 29.5% N/A 100. N/A 55.6% 5. Percent prescribed a 2-month Miralax program: Among visits associated with a diagnosis of constipation, the proportion where a physician prescribed a maintenance dose of Miralax for at least 2 months 98.3% N/A 100. 6. Percent Received Copy of Action Plan: Among visits associated with a diagnosis of constipation, the proportion of families who receive a written copy of the Action Plan 92. N/A 100. 7. Percent with a 4-week follow up visit: Among visits associated with a diagnosis of constipation, the proportion associated with a face to face follow up visit with the PCP within 4 weeks of this initial diagnosis 30.4% N/A 1.6% 8. Percent with Symptom Improvement at Follow Up Visit: Among children with 4-week follow up visits at the PCP office, the proportion having symptom improvement 89.9% (6/15-5/16) N/A 75. 9a. Percent not received clean out prior to GI visit: Proportion of children with a first-time visit to GI clinic, diagnosed with constipation AND impaction at the time of the visit, NOT receiving at least one cleanout attempt prior to the visit (All GI Visits) 9b. Percent not received clean out prior to GI visit: Proportion of children with a first-time visit to GI clinic, diagnosed with constipation AND impaction at the time of the visit, NOT receiving at least one cleanout attempt prior to the visit (PHO Patients Only) 66. (6/15-5/16) 60. (7/15-6/16) N/A 87.5% N/A 0. 10a Percent with care limited to the PHO Guideline: Proportion of children with a first-time visit to GI clinic and diagnosed with constipation where initial GI management was restricted to the PHO Constipation Guideline (cleanout, maintenance miralax, no scheduled stimulant, no labs, no radiographs) (All GI Visits) 10b Percent with care limited to the PHO Guideline: Proportion of children with a first-time visit to GI clinic and diagnosed with constipation where initial GI management was restricted to the PHO Constipation Guideline (cleanout, maintenance miralax, no scheduled stimulant, no labs, no radiographs) (PHO Patients Only) 56.7% 53.6% (7/15-6/16) 11. Percent Referred by PCP: Among children with a first time visit to GI clinic and diagnosed with constipation, the proportion that were referred by the PCP 43.6% N/A 37.5% N/A 0. N/A 32.1% 12. Median days between PCP Referral and GI Visit: Among children with a first-time visit to GI Clinic, referred by the PCP, and diagnosed with constipation, the median number of days between the PCP referral and the GI clinic visit 25.25 N/A 31.0 13. Percent ED Visits: Among ED visits at CCHMC with a primary diagnosis of constipation, the proportion associated with a OVPCA Practice 21.1% 14. Percent GI Visits: Among FIRST-TIME constipation-associated visits to GI, the proportion associated with a OVPCA Practice 22. 15. Percent GI Referral: Among FIRST-TIME constipation-associated visits to GI, the proportion associated with a referral from an OVPCA Practice 12.6% 16. Number of OVPCA Pratices entering data 17. Number of GI Clinic Doctors with patients in the system N/A 21.9% N/A 19. 9.4% N/A 8.3% 40 N/A 25 15 N/A 27 N/A=not applicable

Cincinnati Children s Hospital Medical Center PHO/OVPCA Constipation Initiative Monthly Report February 2018 Monthly Highlights: To date the network has documented 1865 initial and 512 follow up visits for Constipation in the Primary Care office setting. The PHO web registry interface is being used to gather process data for the PCP interaction. Additional process information is gathered at the Gastroenterology clinic at CCHMC. Key outcome measures, ED visit rates and GI clinic rates are tracked and reported from the EPIC system. All three sources of data are aggregated and charted on this monthly report. Thirty eight of thirty nine community practices are participating the program. One key process being tracked is to insure that the patient family receives a copy of the Constipation Action plan at the initial visit, data indicates that this is happening 98% of the time. Another PCP process measure, the prescribing of a 60-day Miralax clean-out is occurring 95% of the time. In addition to the monthly report data, the PHO has developed a customizable reporting capability that allows process and outcome measures to be displayed for selected groups of practices. CCHMC has approved the Constipation program for Part IV maintenance of certification credit. The process for physician level attesting is completed and has been deployed and communicated to the network. Specific physician and practice level criteria has been identified. To date nineteen PHO physicians have successfully attested and received APB part IV credit using this project. The Constipation program was selected for presentation at the 2018 Anderson Center Quality Expo. Drs. Daniel Mallon and Srikant Iyer presented the results of both the QI intervention package as well as the educational research study that was performed concurrently. At the OVPCA board meeting in February 2018 the program was reviewed and discussed. Overall process and outcome success was noted and plans were considered for transition to sustainability mode. As part of this effort several significant changes to be project will be implemented during calendar year 2018. 1) Eliminate collection of initial visit and follow up visit detail in the PHO web registry 2) Continue to track key hospital outcome measurement, GI referral rate, ED and Admission rates for PHO population with a dx of Constipation. 3) Six months after the transition of the program the ABP maintenance of certification will be closed. A general timeline calls for program to be transitioned by EOM June 2018, physicians will be notified sixty days prior to the closure of the program. ABP maintenance of certification will be maintained six months after program closure. Physicians will continue to be able to continue to attest through the end of calendar 2018 (provided that they meet all practice and physician requirements).

May-15 n=1 Jun-15 n=4 Jul-15 n=5 Aug-15 n=4 Oct-15 n=9 Nov-15 n=12 Dec-15 n=11 Jan-16 n=9 Feb-16 n=18 Mar-16 n=21 Apr-16 n=16 May-16 n=13 Jul-16 n=7 Aug-16 n=25 Sep-16 n=23 Oct-16 n=19 Nov-16 n=12 Dec-16 n=9 Jan-17 n=30 Feb-17 n=22 Mar-17 n=30 Apr-17 n=19 May-17 n=27 Jun-17 n=21 Jul-17 n=15 Aug-17 n=17 Sep-17 n=18 Oct-17 n=14 Nov-17 n=14 Dec-17 n=11 Feb-18 n=18 May-15 n=1 Jun-15 n=4 Jul-15 n=5 Aug-15 n=4 Oct-15 n=9 Nov-15 n=12 Dec-15 n=11 Jan-16 n=9 Feb-16 n=18 Mar-16 n=21 Apr-16 n=16 May-16 n=13 Jul-16 n=7 Aug-16 n=25 Sep-16 n=23 Oct-16 n=19 Nov-16 n=12 Dec-16 n=9 Jan-17 n=30 Feb-17 n=22 Mar-17 n=30 Apr-17 n=19 May-17 n=27 Jun-17 n=21 Jul-17 n=15 Aug-17 n=17 Sep-17 n=18 Oct-17 n=14 Nov-17 n=14 Dec-17 n=11 Feb-18 n=18 Long- OVPCA - Constipation Symptom Distribution Term Goal The proportion of children having: < 2 stools per week, hard or painful stools, (6/16) stool withholding behavior or soiling OVPCA - Percent Impaction Among visits to the PCP office associated with a diagnosis of constipation, the proportion of children having impaction ALL CONSTIPATION ALL CONSTIPATION Constipation Symptoms >=1 Center Line-Mean (85.1%) Percent Impacted Center Line-Mean (19.7%) OVPCA - Percent prescribed a 3-day oral cleanout Among visits where impaction was documented, the proportion prescribed a 3-day oral cleanout regimen OVPCA - Percent with a phone follow up Among visits where impaction was documented, the proportion associated with a phone follow up encounter within 7-10 days of the visit 9/16: EXPAND TO ALL CONSTIPATION Percent 3-Day Oral Cleanout Regimen Prescribed Center Line-Mean (73.8%) Percent with a Phone Follow Up Center Line-Mean (56.1%)

Jun-15 n=4 Jul-15 n=7 Aug-15 n=8 Sep-15 n=8 Oct-15 n=19 Nov-15 n=15 Dec-15 n=20 Jan-16 n=13 Feb-16 n=12 Mar-16 n=30 Apr-16 n=48 May-16 n=46 9 Jul-16 n=22 Aug-16 n=25 Sep-16 n=30 Oct-16 n=25 Nov-16 n=23 Dec-16 n=17 Jan-17 n=22 Feb-17 n=26 Mar-17 n=21 Apr-17 n=20 May-17 n=26 Jun-17 n=26 Jul-17 n=14 Aug-17 n=12 Sep-17 n=16 Oct-17 n=11 Nov-17 n=7 Dec-17 n=13 Jan-18 n=14 Feb-18 n=8 Long- OVPCA - Percent prescribed a 2-month Miralax program Term Goal Among visits associated with a diagnosis of constipation, the proportion (6/16) where a physician prescribed a maintenance dose of Miralax for at least 2 months OVPCA - Constipation Visit Action Plans Percent of Visits that Received Copy of Action Plan 98% 96% 94% 92% 88% 86% 84% 10/15: SPREAD PHASE 1 TO 10 BOARD MEMBER PRACTICES 10/15: SPREAD PHASE 1 TO 10 BOARD MEMBER PRACTICES 82% Percent 2-Month Miralax Program Prescribed Center Line-Mean (98.1%) PERCENT RECEIVED ACTION PLAN Center Line-Mean (95.1%) Goal () OVPCA - Percent with a 4-week follow up visit Among visits associated with a diagnosis of constipation, the proportion associated with a face to face follow up visit with the PCP within 4 weeks of this initial diagnosis OVPCA - Percent with Symptom Improvement at Follow Up Visit Among children with 4-week follow up visits at the PCP office, the proportion having symptom improvement 8/16: OVPCA BOARD REMOVED REQUIREMENT PERCENT WITH 4 WEEK FOLLOW VISIT Center Line-Mean (12.8%) PERCENT WITH SYMPTOM IMPROVEMENT AT FOLLOW VISIT Center Line-Mean (82.8%)

Jun-15 n=2 Jul-15 n=18 Aug-15 n=16 Sep-15 n=11 Oct-15 n=29 Nov-15 n=54 Dec-15 n=36 Jan-16 n=28 Feb-16 n=55 Mar-16 n=29 Apr-16 n=47 May-16 n=43 Jun-16 n=12 Jul-16 n=18 Aug-16 n=34 Sep-16 n=28 Oct-16 n=28 Nov-16 n=18 Dec-16 n=20 Jan-17 n=14 Feb-17 n=13 Mar-17 n=22 Apr-17 n=15 May-17 n=15 Jun-17 n=17 Jul-17 n=8 Aug-17 n=10 Sep-17 n=8 Oct-17 n=10 Nov-17 n=6 Dec-17 n=3 Feb-18 n=8 Jul-15 n=3 Aug-15 n=2 Oct-15 n=7 Dec-15 n=15 Jan-16 n=4 Feb-16 n=17 Mar-16 n=6 Apr-16 n=6 May-16 n=7 Jul-16 n=4 Aug-16 n=7 Sep-16 n=5 Oct-16 n=4 Nov-16 n=3 Dec-16 n=5 Jan-17 n=2 Feb-17 n=5 Mar-17 n=5 Apr-17 n=2 May-17 n=1 Jun-17 n=5 Jul-17 n=2 Aug-17 n=0 Sep-17 n=0 Oct-17 n=0 Nov-17 n=0 Dec-17 n=1 Jan-18 n=2 Feb-18 n=0 Jun-15 n=2 Jul-15 n=18 Aug-15 n=16 Sep-15 n=11 Oct-15 n=29 Nov-15 n=54 Dec-15 n=36 Jan-16 n=28 Feb-16 n=55 Mar-16 n=29 Apr-16 n=47 May-16 n=43 Jun-16 n=12 Jul-16 n=18 Aug-16 n=34 Sep-16 n=28 Oct-16 n=28 Nov-16 n=18 Dec-16 n=20 Jan-17 n=14 Feb-17 n=13 Mar-17 n=22 Apr-17 n=15 May-17 n=15 Jun-17 n=17 Jul-17 n=8 Aug-17 n=10 Sep-17 n=8 Oct-17 n=10 Nov-17 n=6 Dec-17 n=3 Feb-18 n=8 Jul-15 n=3 Aug-15 n=2 Oct-15 n=7 Dec-15 n=15 Jan-16 n=4 Feb-16 n=17 Mar-16 n=6 Apr-16 n=6 May-16 n=8 Jul-16 n=4 Aug-16 n=7 Sep-16 n=5 Oct-16 n=4 Nov-16 n=3 Dec-16 n=5 Jan-17 n=2 Feb-17 n=5 Mar-17 n=5 Apr-17 n=2 May-17 n=1 Jun-17 n=5 Jul-17 n=2 Aug-17 n=0 Sep-17 n=0 Oct-17 n=0 Nov-17 n=0 Dec-17 n=1 Jan-18 n=2 Feb-18 n=0 Long- CCHMC - Percent not received clean out prior to GI visit Proportion Term Goal of children with a first-time visit to GI clinic, diagnosed with constipation (6/16) AND impaction at the time of the visit, NOT receiving at least one cleanout attempt prior to the visit (All GI CCHMC - Percent not receiving clean out prior to GI visit Proportion of children with a first-time visit to GI clinic, diagnosed with constipation AND impaction at the time of the visit, NOT receiving at least one cleanout attempt prior to the visit (PHO) PERCENT NOT RECEIVING CLEAN OUT PRIOR TO GI VISIT Centerline - Mean (66.) PERCENT NOT RECEIVING CLEAN OUT PRIOR TO GI VISIT Centerline - Mean (60.) CCHMC - Percent with care limited to the PHO Guideline Proportion of children with a first-time visit to GI clinic and diagnosed with constipation where initial GI management was restricted to the PHO Constipation Guideline (cleanout, maintenance miralax, CCHMC - Percent with care limited to the PHO Guideline Proportion of children with a first-time visit to GI clinic and diagnosed with constipation where initial GI management was restricted to the PHO Constipation Guideline (cleanout, maintenance miralax, 3 PROVIDERS b PERCENT PHO GUIDELINES ONLY AT VISIT Centerline - Mean (28.8% ) PERCENT PHO GUIDELINES ONLY AT VISIT Centerline - Mean (53.6% )

May-14 n=149 Jun-14 n=145 Jul-14 n=169 Aug-14 n=157 Sep-14 n=162 Oct-14 n=205 Nov-14 n=183 Dec-14 n=192 Jan-15 n=192 Feb-15 n=180 Mar-15 n=207 Apr-15 n=202 May-15 n=185 Jun-15 n=163 5 Aug-15 n=164 Sep-15 n=153 Oct-15 n=161 Nov-15 n=169 Dec-15 n=191 Jan-16 n=219 Feb-16 n=187 Mar-16 n=173 Apr-16 n=170 May-16 n=128 Jun-16 n=131 Jul-16 n=151 Aug-16 n=175 Sep-16 n=180 Oct-16 n=212 Nov-16 n=197 Dec-16 n=190 Jan-17 n=241 Feb-17 n=217 Mar-17 n=226 Apr-17 n=163 May-17 n=192 Jun-17 n=166 Jul-17 n=154 Aug-17 n=196 Sep-17 n=171 Oct-17 n=197 Nov-17 n=185 Dec-17 n=192 Jan-18 n=187 Feb-18 n=178 May-14 n=73 Jun-14 n=94 Jul-14 n=98 Aug-14 n=85 Sep-14 n=90 Oct-14 n=98 Nov-14 n=75 Dec-14 n=91 Jan-15 n=89 Feb-15 n=87 Mar-15 n=108 Apr-15 n=87 May-15 n=130 Jun-15 n=97 Jul-15 n=109 Aug-15 n=96 Sep-15 n=90 Oct-15 n=90 1 Dec-15 n=93 Jan-16 n=79 Feb-16 n=114 Mar-16 n=112 Apr-16 n=103 May-16 n=99 Jun-16 n=81 Jul-16 n=79 Aug-16 n=103 Sep-16 n=91 Oct-16 n=93 Nov-16 n=110 Dec-16 n=91 Jan-17 n=102 Feb-17 n=94 Mar-17 n=112 Apr-17 n=100 May-17 n=101 Jun-17 n=74 Jul-17 n=118 Aug-17 n=119 Sep-17 n=94 Oct-17 n=100 Nov-17 n=127 Dec-17 n=86 Jan-18 n=96 Feb-18 n=84 May-14 n=149 Jun-14 n=145 Jul-14 n=169 Aug-14 n=157 Sep-14 n=162 Oct-14 n=205 Nov-14 n=183 Dec-14 n=192 Jan-15 n=192 Feb-15 n=180 Mar-15 n=207 Apr-15 n=202 May-15 n=185 Jun-15 n=163 5 Aug-15 n=164 Sep-15 n=153 Oct-15 n=161 Nov-15 n=169 Dec-15 n=191 Jan-16 n=219 Feb-16 n=187 Mar-16 n=173 Apr-16 n=170 May-16 n=128 Jun-16 n=131 Jul-16 n=151 Aug-16 n=175 Sep-16 n=180 Oct-16 n=212 Nov-16 n=197 Dec-16 n=190 Jan-17 n=241 Feb-17 n=217 Mar-17 n=226 Apr-17 n=163 May-17 n=192 Jun-17 n=166 Jul-17 n=154 Aug-17 n=196 Sep-17 n=171 Oct-17 n=197 Nov-17 n=185 Dec-17 n=192 Jan-18 n=187 Feb-18 n=178 May-14 n=73 n= Jun-14 n=94 n= Jul-14 n=98 n= Aug-14 n=85 n= Sep-14 n=90 n= Oct-14 n=98 n= Nov-14 n=75 n= Dec-14 n=91 n= Jan-15 n=89 n= Feb-15 n=87 n= Mar-15 n=108 n= Apr-15 n=87 n= May-15 n=130 n= Jun-15 n=97 n= Jul-15 n=109 n= Aug-15 n=96 n= Sep-15 n=90 n= Oct-15 n=90 n= 1 n= Dec-15 n=93 n= Jan-16 n=79 n= Feb-16 n=114 n= Mar-16 n=112 n= Apr-16 n=103 n= May-16 n=99 n= Jun-16 n=81 n= Jul-16 n=79 n= Aug-16 n=103 n= Sep-16 n=91 n= Oct-16 n=93 n= Nov-16 n=110 n= Dec-16 n=91 n= Jan-17 n=102 n= Feb-17 n=94 n= Mar-17 n=112 n= Apr-17 n=100 n= May-17 n=101 n= Jun-17 n=74 n= Jul-17 n=118 n= Aug-17 n=119 n= Sep-17 n=94 n= Oct-17 n=100 n= Nov-17 n=127 n= Dec-17 n=86 n= Jan-18 n=96 n= Feb-18 n=84 n= Median Number odf Days CCHMC - Gastroenterology New Visits for Constipation Percent of Visits With an EPIC Referral from the PCP CCHMC - Gastroenterology New Visits for Constipation with an EPIC Referral Median Days Between EPIC Referral Date and Visit Date 60 50 40 30 20 10 0 Pct PCP Referral Center Line-Mean (43.4%) UCL LCL Median Days Between Referral and Clinic Date Overall Median (34.5) CCHMC - ED and UC Visits with a Primary Diagnosis of Constipation Percent of Visits With a PHO Provider Listed as the PCP CCHMC - Gastroenterology New Visits for Constipation Percent of Visits With an EPIC Referral from a PHO Provider Pct PHO PCP Center Line-Mean (21.) UCL LCL Pct PHO Referral Center Line-Mean (12.) UCL LCL Goal (9.4%)

June-15 n=1 July-15 n=2 Aug-15 n=2 Sept-15 n=2 Oct-15 n=6 Dec-15 n=11 Jan-16 n=12 Feb-16 n=14 Mar-16 n=14 Apr-16 n=21 May-16 n=21 June-16 n=23 July-16 n=23 Aug-16 n=23 Sept-16 n=24 Oct-16 n=24 Nov-16 n=24 Dec-16 n=25 Jan-17 n=25 Feb-17 n=26 Mar-17 n=26 Apr-17 n=26 May-17 n=27 June-17 n=27 July-17 n=27 Aug-17 n=27 Sept-17 n=27 Oct-17 n=27 Nov-17 n=27 Dec-17 n=27 Jan-18 n=27 Feb-18 n=27 May-14 n=73 Jun-14 n=94 Jul-14 n=98 Aug-14 n=85 Sep-14 n=90 Oct-14 n=98 Nov-14 n=75 Dec-14 n=91 Jan-15 n=89 Feb-15 n=87 Mar-15 n=108 Apr-15 n=87 May-15 n=130 Jun-15 n=97 Jul-15 n=109 Aug-15 n=96 Sep-15 n=90 Oct-15 n=90 1 Dec-15 n=93 Jan-16 n=79 Feb-16 n=114 Mar-16 n=112 Apr-16 n=103 May-16 n=99 Jun-16 n=81 Jul-16 n=79 Aug-16 n=103 Sep-16 n=91 Oct-16 n=93 Nov-16 n=110 Dec-16 n=91 Jan-17 n=102 Feb-17 n=94 Mar-17 n=112 Apr-17 n=100 May-17 n=101 Jun-17 n=74 Jun-17 n=118 Aug-17 n=119 Sep-17 n=94 Oct-17 n=100 Nov-17 n=127 Dec-17 n=86 Jan-18 n=96 Feb-18 n=84 May-15 n=4 Jun-15 n=2 Jul-15 n=3 Aug-15 n=4 Sep-15 n=7 Oct-15 n=8 Dec-15 n=10 Jan-16 n=15 Feb-16 n=17 Mar-16 n=25 Apr-16 n=22 May-16 n=21 Jun-16 n=15 Jul-16 n=15 Aug-16 n=22 Sep-16 n=22 Oct-16 n=19 Nov-16 n=17 Dec-16 n=17 Jan-17 n=21 Feb-17 n=20 Mar-17 n=21 Apr-17 n=20 May-17 n=22 Jun-17 n=15 Jul-17 n=19 Aug-17 n=17 Sep-17 n=17 Oct-17 n=16 Nov-17 n=17 Dec-17 n=19 Jan-18 n=12 Feb-18 n=13 CCHMC - Gastroenterology New Visits for Constipation Percent of Visits With a PHO Provider Listed as the PCP OVPCA - Practices Entering Data By Month 27 26 25 24 23 22 21 20 19 18 17 16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 0 10/15: SPREAD PHASE 1 TO 10 BOARD MEMBER PRACTICES Pct PHO PCP Center Line-Mean (18.7%) UCL LCL Number of Practices That Have Entered Data GI Clinic Doctors Entering Data By Month 29 28 27 26 25 24 23 22 21 20 19 18 17 16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 0 Number of GI Clinic Doctors That Have Entered Data